Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study-Reference-Cited by-同舟云学术

Cardiovascular safety of evogliptin in patients with type 2 diabetes: A nationwide cohort study

Published:2021-02-10 Issue:6 Volume:23 Page:1232-1241
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Park So‐Hee¹,Jeong Han Eol¹,Oh In‐Sun¹,Hong Sang‐Mo²,Yu Sung Hoon²,Lee Chang Beom²,Shin Ju‐Young¹³^ORCID

Affiliation:

1. School of Pharmacy Sungkyunkwan University Suwon Republic of Korea

2. Department of Internal Medicine Hanyang University Guri Hospital Guri Republic of Korea

3. Department of Clinical Research Design & Evaluation, Samsung Advanced Institute for Health Sciences & Technology Sungkyunkwan University Seoul Republic of Korea

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14330

Reference43 articles.

1. Clinical Use of DPP-4 Inhibitors

2. Cardiovascular effects of gliptins

3. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

4. Guidance for Industry on Diabetes Mellitus‐Evaluating Cardiovascular Risk in New Antidiabetic Therapies to Treat Type 2 Diabetes.https://www.federalregister.gov/documents/2008/12/19/E8‐30086/guidance‐for‐industry‐on‐diabetes‐mellitus‐evaluating‐cardiovascular‐risk‐in‐new‐antidiabetic. Accessed May 1 2020.

5. Cardiovascular safety of DPP-4 inhibitors compared with sulphonylureas: Results of randomized controlled trials and observational studies

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiovascular safety of evogliptin dual and triple therapy in patients with type 2 diabetes: a nationwide cohort study;BMJ Open;2024-04

2. Diabetic Cardiomyopathy—From Basics through Diagnosis to Treatment;Biomedicines;2024-03-29

3. Evaluation of the Ejection Pressure for Tracking Internal Cracks during Compaction in Bilayer Tablet Formulations Using Experimental and Finite Element Methods;Pharmaceuticals;2024-03-02

4. The Effect of Compression Pressure on the First Layer Surface Roughness and Delamination of Metformin and Evogliptin Bilayer and Trilayer Tablets;Pharmaceuticals;2023-10-26

5. Safety of sodium‐glucose co‐transporter‐2 inhibitors on amputation across categories of baseline cardiovascular disease and diuretics use in patients with type 2 diabetes;Diabetes, Obesity and Metabolism;2023-07-28